Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Cryopreservation Improves Longer-Lasting Blood Supply

By LabMedica International staff writers
Posted on 01 Dec 2016
The development of highly efficient methods to cryopreserve cells, tissues, and organs is becoming exceedingly important to meet the increasing demands of emerging cellular therapies. More...
Cryopreservation of blood and stem cells has had tremendous impact on regenerative and transfusion medicine.

Currently, red blood cell (RBC) storage is limited to 42 days at 4 °C, which can result in blood shortages when high numbers of emergency transfusions are required. Although cryopreservation can extend the storage time to 10 years, major limitations to current protocols largely limit this preservation method to rare blood types and autologous RBCs.

Biochemists working with the Canadian Blood Services (Edmonton, AB, Canada) have examined a new class of small molecules with the potential to make the cryopreservation process more practical and give the cells and tissues a longer shelf life. Low-molecular-weight ice recrystallization inhibitors (IRIs) are ideal cryoprotectants that control the growth of ice and mitigate cell damage during freezing.

The team performed a detailed study correlating the ice recrystallization inhibition activity and the cryopreservation ability with the structure of O-aryl-glycosides. Many effective IRIs are efficient cryoadditives for the freezing of red blood cells (RBCs). One effective cryoadditive did not inhibit ice recrystallization but instead inhibited ice nucleation, demonstrating the significance of inhibiting both processes and illustrating the importance of this emerging class of cryoprotectants.

The team showed that two of the molecules in the class were effective at preventing ice from forming in red blood cells frozen at -80 °C. Adding the new protectants reduced the needed concentration of glycerol from 40% to between 10% and 15%. Lowering the amount of glycerol could help minimize the time required to prepare thawed red blood cells for transfusion, and thus, be ready for use in patients faster.

The authors concluded that the O-aryl-glycosides represent a novel class of small-molecule IRIs, many of which were effective cryoadditives used for the freezing of RBCs with reduced glycerol concentrations. The synthesis of these structurally simple molecules is amenable to large-scale preparation for use in cryopreservation applications to improve upon cryopreservation protocols of therapeutically important cells. The study was published on October 24, 2016, in the journal ACS Omega.

Related Links:
Canadian Blood Services


New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Candida Glabrata Test
ELIchrom Glabrata
New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
Image: Pancreatic cancer diagnosis (Photo courtesy of World Journal of Gastroenterology)

AI-Driven Preliminary Testing for Pancreatic Cancer Enhances Prognosis

Pancreatic cancer poses a major global health threat due to its high mortality rate, with 467,409 deaths and 510,992 new cases reported worldwide in 2022. Often referred to as the "king" of all cancers,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.